Istituto Cardiocentro
Lugano, Canton Ticino, 6900, Switzerland
NCT Number: NCT06823141
The goal of this clinical trial is to learn if the use of virtual reality immersion during pre-oxygenation before general anesthesia could be feasible and beneficial for the patient. The main questions it aims to answer are:
Does virtual reality immersion during pre-oxygenation reduce patient's anxiety? Does it impact patient's and anaesthetist's comfort? Is this technique easy to implement?
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lugano, Canton Ticino, 6900, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The study intervention, defined by the use of a virtual reality, exclusively takes place during the pre-oxygenation period where the patient is exposed to a virtual reality immersion scenario.
Time frame: 4 min after the beginning of pre-oxygenation.
Anxiety will be assessed with the Visual Analogue Scale for Anxiety (VASA) scale ranging from 0 to 10 (0 corresponds to the lowest level of anxiety and 10 to maximal level of anxiety).
Time frame: The four time points are: in the ward on the day of surgery, in the theater once the patient is monitored and before pre-oxygenation, 4 min after the beginning of pre-oxygenation, in the ward at least two hours after the end of surgery.
Change in Visual Analogue Scale for anxiety (VASA) between 4 time points. VASA scale ranges from 0 to 10 with 10 corresponding to the highest level of anxiety.
Time frame: During study recruitment.
Rate of patients accepting to participate to the study. The number of patients accepting to participate will be descrided in percent (%) with the denominator beeing the sum of patients who accepted and refused to participate to the study.
Time frame: From the beginning to the end of the pre-oxygenation period.
Rate of patient who completed pre-oxygenation with the virtual reality headset. The rate of patient who completed the pre-oxygenation with the virtual reality headset will be measured in percent (%).
Time frame: At two times: on the day of surgery while the patient is still in the ward and after entry in the OR up to the beginning of pre-oxygenation.
The APAIS score is a validated score to evaluate anxiety in the preoperative context. It ranges from 6 to 30 with the highest score corresponding to a high level of anxiety.
Time frame: The four time points are: in the ward on the day of surgery, the first blood pressure measured in theater, at the beginning of the pre-oxygenation and at the end of the pre-oxygenation (just before the beginning of the general anaesthesia induction)
Variation of blood pressure (systolic arterial pressure, diastolic arterial pressure, mean arterial pressure) between four time points.
Time frame: The four time points are: in the ward on the day of surgery, the first oxygen saturation measured in theater, at the beginning of the pre-oxygenation and at the end of the pre-oxygenation (just before the beginning of the general anaesthesia induction)
Variation of oxygen saturation measured with finger pulsoxymeter between four time points.
Time frame: The four time points are: in the ward on the day of surgery, the first heart rate measured in theater, at the beginning of the pre-oxygenation and at the end of the pre-oxygenation (just before the beginning of the general anaesthesia induction)
Variation of heart rate measured between four time points.
Time frame: During pre-oxygenation (at 2 minutes after pre-oxygenation initiation).
Patient will be asked it's level of comfort during pre-oxygenation with a Likert scale ranging from 0 to 10 (with 0 corresponding to the maximum comfort and 10 to the minimal comfort).
Time frame: From the beginning to the end of the pre-oxygenation period.
Incidence of cybersickness during the pre-oxygenation period in percent (%).
Time frame: From the beginning to the end of the pre-oxygenation period.
Evaluation of the involved anesthetic team comfort regarding the pre-oxygenation technique with a Likert scale ranging from 1 to 5 (1 corresponding to the lowest level of comfort and 5 to the highest level of comfort).
Time frame: From the beginning to the end of the pre-oxygenation period.
Perceived comfort of the patient during pre-oxygenation by the involved anesthetist team with a Likert scale ranging from 1 to 5 (1 beeing the lowest level of comfort and 5 beeing the highest level of comfort).
Time frame: From the beginning of the awakening after general anesthesia to the removal of the airway device.
Wake up quality test with a 3-point scale (good, satisfactory, poor).
Time frame: From 2 hours after the end of anesthesia to the first day after surgery.
Evaluation of patient's satisfaction regarding the pre-oxygenation technique with a 5-point Likert scale (1 beeing the lowest level of satisfaction and 5 the highest level of satisfaction)
Time frame: From 2 hours after the end of anesthesia to the first day after surgery.
Qualitative post-operative survey with questions about patient's experience during pre-oxygenation.
Ente Ospedaliero Cantonale, Bellinzona
Other
Effect of Virtual Reality Immersion on Patient's Anxiety During Pre-oxygenation Before General Anaesthesia: a Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07334522
Agnosia, Anxiety
Karbala, Iraq
View Trial DetailsNCT05729347
Anxiety, Anxiety Disorders
Stanford, California, United States
View Trial DetailsNCT06804928
Anxiety, Anxiety Disorders
Samsun, Merkez, Turkey (Türkiye)
View Trial DetailsNCT07580885
Agnosia, Anxiety
Gaziantep, Turkey (Türkiye)
View Trial Details